A total of 160 Private Equity/Venture Financing deals (pending and completed) were announced in the Healthcare of the North America region, driven by Artificial Intelligence, in the last twelve months resulting in a total deal value of over $7,010.2 million. In the LTM period, October 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $1,031.9 million, resulting in an average deal value of $68.8 million during that month. On the other hand, the month of June 2021 was the most prolific in terms of deal volume, recording a total of 17 deals, resulting in an average deal value of $43.1 million during that month.
Of the 160 deals, the deal secured between Amgen Ventures LLC; Intermountain Ventures; McKesson Ventures; Merck Global Health Innovation Fund LLC; Northpond Ventures LLC; Pfizer Venture Investments; Population Health Partners LLC; The Carlyle Group Inc. and Saama Technologies Inc, was the largest Private Equity/Venture Financing deal in the North America Healthcare sector driven by Artificial Intelligence, which was valued at $430.0 million and was completed on October 20, 2021. The second-largest deal was between 5Y Capital; Orbimed Advisors LLC; RRJ Capital; Sequoia Capital Operations LLC; Sino Biopharmaceutical Ltd and XtalPi Inc, while the third-largest deal was between B Capital Group Management, L.P.; Baidu Ventures; Bold Capital Partners; CITIC Industrial Investment Fund Management Co Ltd; Deerfield Management Co LP; Eight Roads Ventures; Formic Ventures; Lake Bleu Capital; Lilly Asia ventures; Maison Capital Group; Mirae Asset Capital Co Ltd; Orbimed Advisors LLC; Pavilion Capital Partners LLC; President International Development Corporation; Qiming Venture Partners; Sage Partners; Sequoia Capital China; Sinovation Ventures; Warburg Pincus LLC and InSilico Medicine. The 5Y Capital; Orbimed Advisors LLC; RRJ Capital; Sequoia Capital Operations LLC; Sino Biopharmaceutical Ltd-XtalPi Inc deal and the B Capital Group Management, L.P.; Baidu Ventures; Bold Capital Partners; CITIC Industrial Investment Fund Management Co Ltd; Deerfield Management Co LP; Eight Roads Ventures; Formic Ventures; Lake Bleu Capital; Lilly Asia ventures; Maison Capital Group; Mirae Asset Capital Co Ltd; Orbimed Advisors LLC; Pavilion Capital Partners LLC; President International Development Corporation; Qiming Venture Partners; Sage Partners; Sequoia Capital China; Sinovation Ventures; Warburg Pincus LLC-InSilico Medicine deal were valued at $400.0 million and $255.0 million, respectively. The fourth-largest deal was between Mubadala Investment Co-Certara USA Inc valued at $250.0 million, whereas the deal between Alexandria Venture Investments; Ally Bridge Group; ARCH Venture Partners LP; ArrowMark Partners; Deep Track Capital LP; Eight Partners LLC; Great Point Ventures Fund; Icon Ventures Inc; Illumina Ventures; Janus Henderson Investors; Koch Disruptive Technologies; Logos Global Management LLC; Ono Venture Investment Inc; Piper Heartland Healthcare Capital, LLC; Ridgeback Capital Investment LLC; Section 32; Surveyor Capital Ltd; T Rowe Price Associates Inc; Talos VC; Tao Capital Partners; TCG Crossover; Tekla Capital Management LLC; Temasek Holdings (Private) Ltd; Vertex Pharmaceuticals Inc; Woodline Partners-Arbor Biotechnologies Inc; Immunai Inc valued at $215.0 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $1,550.0 million and accounted for nearly 22.11% of the total deals (by value) announced during the last twelve months. The North America region accounted for 66.18% of the total Private Equity/Venture Financing deals done globally, and accounted for 56.14% of the total deal size on a global scale.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Ireland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward